NCT05033236View on ClinicalTrials.gov

Platelets and Complement Activation in Coronary Artery Bypass Graft Surgery (CABG)

CompletedOBSERVATIONAL
Enrollment

190

Participants

Timeline

Start Date

November 23, 2018

Primary Completion Date

June 30, 2022

Study Completion Date

July 30, 2022

Conditions
Cardiopulmonary BypassInflammatory ResponsePlatelet Dysfunction
Trial Locations (1)

6020

University Hospital Innsbruck, Innsbruck

All Listed Sponsors
lead

Medical University Innsbruck

OTHER

NCT05033236 - Platelets and Complement Activation in Coronary Artery Bypass Graft Surgery (CABG) | Biotech Hunter | Biotech Hunter